FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

79605009: 3 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    132068015 Three en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442100016 3 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442101017 3 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    3 Is a General adjectival modifier false Inferred relationship Some
    3 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 2
    Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 3 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 2
    Product containing precisely potassium chloride 3 milligram/1 milliliter and sodium chloride 9 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1
    Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 4.5 mg/mL solution for infusion Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely anhydrous glucose 40 milligram/1 milliliter and potassium chloride 2 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for infusion (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Flupentixol (as flupentixol hydrochloride) 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing only naphazoline and polyvinyl alcohol and zinc sulfate (medicinal product) Count of base of active ingredient False 3 Inferred relationship Some
    Chlorphenamine and methscopolamine and pseudoephedrine only product Count of base of active ingredient False 3 Inferred relationship Some
    Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Some
    Chlorphenamine and phenylephrine and phenyltoloxamine only product Count of base of active ingredient False 3 Inferred relationship Some
    Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form Count of base of active ingredient False 3 Inferred relationship Some
    Product containing only cetyl alcohol and colfosceril and tyloxapol (medicinal product) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing only chlorphenamine and paracetamol and phenylephrine (medicinal product) Count of base of active ingredient False 3 Inferred relationship Some
    Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1
    Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and valsartan 160 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet Count of base of active ingredient False 3 Inferred relationship Some
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Lamivudine 150 mg and nevirapine 200 mg and stavudine 30 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing only aliskiren and amlodipine and hydrochlorothiazide in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Some
    Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram and valsartan 320 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Tobramycin 3 mg/mL eye solution Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing only amlodipine and hydrochlorothiazide and olmesartan in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely pramipexole dihydrochloride 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and valsartan 160 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely gentamicin sulfate 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing only amlodipine and hydrochlorothiazide and valsartan in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/g eye ointment Has concentration strength numerator value False 3 Inferred relationship Some 1
    Tobramycin 3 mg/g eye ointment Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing only caffeine and isometheptene and paracetamol in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely hydromorphone hydrochloride 3 milligram/1 each conventional release rectal suppository (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Dexamethasone 500 microgram/mL and tobramycin 3 mg/mL eye suspension Has concentration strength numerator value False 3 Inferred relationship Some 2
    Product containing only magnesium hydroxide and omeprazole and sodium bicarbonate in oral dose form (medicinal product form) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely magnesium hydroxide 700 milligram and omeprazole 20 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Paliperidone 3 mg prolonged-release oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely lamivudine 150 milligram and nevirapine 200 milligram and stavudine 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely glyceryl trinitrate 3 milligram/1 each prolonged-release buccal tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Adapalene 3 mg/g cutaneous gel Has concentration strength numerator value False 3 Inferred relationship Some 1
    Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release ear solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1
    Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely lamivudine 30 milligram and nevirapine 50 milligram and stavudine 6 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 3
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Has concentration strength numerator value False 3 Inferred relationship Some 2
    Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 3
    Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution Count of base of active ingredient False 3 Inferred relationship Some
    Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1
    Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Pseudoephedrine hydrochloride 3 mg/mL oral solution Has concentration strength numerator value False 3 Inferred relationship Some 1
    Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution Count of base of active ingredient False 3 Inferred relationship Some
    Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream Count of base of active ingredient False 3 Inferred relationship Some
    Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1

    Start Previous Page 4 of 5 End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start